doi:10.1007/s10753-018-00954-3 99
Be cautious of common pitfalls such as missing signatures or failing to provide complete drug details, which could delay processing
In this context, GLP-1s and other weightmanagement medications may be most effective when they are: Anchored to clear clinical criteria and outcome-based continuation policies, so that ongoing coverage aligns with demonstrated health improvement and adherence Integrated into broader chronic disease and wellness strategies that emphasize long-term behavioral change, rather than positioned as standalone, short-term solutions By incorporating this emerging evidence into GLP1 benefit design, employers can better balance access, outcomes, and sustainability, supporting employee health while setting realistic expectations about the need for ongoing management to maintain results over time
Boteon, Y
How to Maintain Weight After a GLP-1 Medication By Lizzie Streit, MS, RDN, LD GLP-1 receptor agonists, such as Ozempic and Wegovy, have helped thousands of people lose weight and manage type 2 diabetes, heart disease, and other conditions
Although side effects of long-term use are typically mild, some experts are concerned about its safety
:format(webp))
